Genome Medicine announces a new series on microbes in health and disease
In 2013 Genome Medicine will launch a new thematic series focusing on Microbes in health and disease. This series will highlight advances in genome-scale and other ‘omic approaches for studying...
View ArticlePresentation of the Microbiology, Immunology, Infection and Inflammation...
Each year, BioMed Central presents awards in recognition of top quality research published in its journals. The winners of the Microbiology, Immunology, Infection and Inflammation category award are...
View ArticleLinking the microbiome and colorectal cancer: an author Q+A
What is currently known about the link between the microbiome and colorectal cancer? Many studies have investigated the link between the microbiome and colon cancer, with insightful findings. Several...
View ArticleUsing the microbiome to predict risk of infection following chemotherapy
Bacteremia, or bloodstream infection, is a serious side-effect of chemotherapy and a leading cause of death in cancer patients. It is especially common in patients receiving high-dose chemotherapy to...
View ArticleDo probiotics have a beneficial effect on healthy adults?
According to a recent report the global market for probiotics is expected to reach USD 52.35 billion by 2020. Keeping a strong immune system is related to gut health so growing consumer awareness...
View ArticleAdapting and adopting microbiome data into clinical practice
Numerous sophisticated laboratory and computational methods have been developed to identify the sheer complexity of the composition of microbial communities, as well as the molecular interactions among...
View ArticleThe gut microbiota and Parkinson’s disease – what we know so far
At present, the progression of Parkinson’s disease (PD) symptoms cannot be halted and the disease process seems to progress relentlessly. Medications and treatments aim at alleviating clinical symptoms...
View ArticleGenome Medicine announces a new series on microbes in health and disease
In 2013 Genome Medicine will launch a new thematic series focusing on Microbes in health and disease. This series will highlight advances in genome-scale and other ‘omic approaches for studying...
View ArticlePresentation of the Microbiology, Immunology, Infection and Inflammation...
Each year, BioMed Central presents awards in recognition of top quality research published in its journals. The winners of the Microbiology, Immunology, Infection and Inflammation category award are...
View ArticleLinking the microbiome and colorectal cancer: an author Q+A
What is currently known about the link between the microbiome and colorectal cancer? Many studies have investigated the link between the microbiome and colon cancer, with insightful findings. Several...
View ArticleUsing the microbiome to predict risk of infection following chemotherapy
Bacteremia, or bloodstream infection, is a serious side-effect of chemotherapy and a leading cause of death in cancer patients. It is especially common in patients receiving high-dose chemotherapy to...
View ArticleDo probiotics have a beneficial effect on healthy adults?
According to a recent report the global market for probiotics is expected to reach USD 52.35 billion by 2020. Keeping a strong immune system is related to gut health so growing consumer awareness...
View ArticleAdapting and adopting microbiome data into clinical practice
Numerous sophisticated laboratory and computational methods have been developed to identify the sheer complexity of the composition of microbial communities, as well as the molecular interactions among...
View ArticleThe gut microbiota and Parkinson’s disease – what we know so far
At present, the progression of Parkinson’s disease (PD) symptoms cannot be halted and the disease process seems to progress relentlessly. Medications and treatments aim at alleviating clinical symptoms...
View Article
More Pages to Explore .....